MedTech Dive November 12, 2018
Meg Bryant

Big players like Medtronic see potential in R&D, marketing and education

Osseus Fusion Systems’ 3D printed titanium spinal implants won FDA clearance earlier this year, joining more than 100 devices and one drug currently on the market manufactured on 3D printers.

FDA Commissioner Scott Gottlieb has called 3D printing a transformative technology that could disrupt medical practice, and the agency is scrambling to keep abreast of new regulatory challenges. ​

Known as additive manufacturing, the process involves production of three-dimensional objects using a digital file. The printer layers successive images or files on top of one another until a solid 3D object is formed. The process allows designers to create 3D models of a patient’s anatomy for use in diagnosis...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Healthcare System, Medical Devices, Technology, Trends
WASP Highlights Advances in Healthcare 3D Printing at Italy’s Exposanità 2024
3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance
3D Printing Market Hits $14.7B Amid Challenges in 2023
World’s First Bioprinted Trachea Transplant Marks a New Era in Medical Innovation
AI-Powered 3D Printing Redefines Implant Surgery

Share This Article